Evolysse Form and Smooth Injectable HA Gels Hit Market
Evolus launched its Evolysse Form and Evolysse Smooth injectable HA gels on April 18, following a national webcast and early access program involving over 1,000 aesthetic practices.
Evolus launched its Evolysse Form and Evolysse Smooth injectable HA gels on April 18, following a national webcast and early access program involving over 1,000 aesthetic practices.
A randomized controlled study of Sofwave’s FDA-cleared Pure Impact VIP platform found functional gains, with most improvements sustained four weeks after treatment.